Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
NCT00409526
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
Sub-Investigator left U of C
Conditions
Pulmonary Hypertension
Interventions
DRUG:
Inhaled Iloprost
Sponsor
University of Chicago